ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF
30.26
-0.2414
-0.79%
成交量:
57
成交额:
1,722
市值:
2,178.62万
市盈率:
- -
高:
30.26
开:
30.50
低:
30.26
收:
30.50
52周最高:
32.57
52周最低:
24.64
股本:
72.00万
流通股本:
72.00万
量比:
0.05
换手率:
0.01%
股息:
0.72
股息率:
2.37%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
金斯瑞生物科技:传奇生物核心产品第三季度贸易销售净额约7.1亿美元
南方财经网
·
昨天
传奇生物启动首届精英资助计划,推动多发性骨髓瘤下一代CAR-T创新
美股速递
·
10/01
传奇生物:Huang Ying拟出售6.98万股,市值约130.21万美元
南方财经网
·
09/23
近40位药企高管密集跳槽
国际金融报
·
09/21
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/MEMS"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","market":"US","secType":"STK","nameCN":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","latestPrice":30.2586,"timestamp":1791921600000,"preClose":30.5,"halted":0,"volume":57,"delay":0,"changeRate":-0.007914754098360614,"floatShares":720000,"shares":720000,"eps":0,"marketStatus":"盘后交易","change":-0.2414,"latestTime":"10-13 17:11:13 EDT","open":30.5,"high":30.2586,"low":30.2586,"amount":1722,"amplitude":0,"askPrice":37.77,"askSize":200,"bidPrice":22.67,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791936000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":30.5,"sharesOutstanding":720000,"nav":30.784,"aum":22164395.9,"dividendRate":0.023686,"bidAskSpread":0,"volumeRatio":0.052719},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEMS\",,,,,undefined,":{"symbol":"MEMS","floatShares":720000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.052719,"shares":720000,"dividePrice":0.7167,"high":30.2586,"amplitude":0,"preClose":30.5,"low":30.2586,"week52Low":24.6357,"pbRate":"--","week52High":32.565,"institutionHeld":0,"latestPrice":30.2586,"eps":0,"divideRate":0.023686,"volume":57,"delay":0,"ttmEps":0,"open":30.5,"prevYearClose":25.545,"prevWeekClose":30.5983,"prevMonthClose":30.1005,"prevQuarterClose":30.1005,"fiveDayClose":30.94,"twentyDayClose":29.6737,"sixtyDayClose":29.4219},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEMS\",params:#limit:5,,,undefined,":[{"date":"2025-12-17","symbol":"MEMS","amount":0.71648,"announcedDate":"2025-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-17","defaultRemindTime":1765981800000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-22","payableDate":"2025-12-17","currency":"USD","dateTimestamp":1765947600000,"payDate":"2025-12-22"},{"date":"2024-12-18","symbol":"MEMS","amount":0.33495,"announcedDate":"2024-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-18","defaultRemindTime":1734532200000,"name":"MATTHEWS EMERGING MARKETS DISCOVERY ACTIVE ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-18","currency":"USD","dateTimestamp":1734498000000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEMS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-18","recordDate":"2024-12-18","paymentDate":"2024-12-23","value":0.33495,"currency":"USD"},{"executeDate":"2025-12-17","recordDate":"2025-12-17","paymentDate":"2025-12-22","value":0.71648,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEMS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEMS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675354717","title":"金斯瑞生物科技:传奇生物核心产品第三季度贸易销售净额约7.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675354717","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675354717?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 20:33","pubTimestamp":1791894780,"startTime":"0","endTime":"0","summary":"南财智讯10月13日电,金斯瑞生物科技(01548.HK)发布自愿公告,公司联营公司传奇生物已向美国证券交易委员会提交相关表格,宣布根据传奇与杨森订立的合作及许可协议,核心产品西达基奥仑赛于截至2026年9月30日止季度产生贸易销售净额约7.1亿美元。贸易销售净额乃基于杨森向传奇提供的资料,传奇与公司均未独立核实该销售数字的准确性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610133894345938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610133894345938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000320264.USD","HK0000320223.HKD","BK1141","LEGN","MEMS","BK4588","BK1576","BK4585","MEDI","01548","BK4505","CANC","BK1583","HK0000306685.HKD","BK4139","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165955052","title":"传奇生物启动首届精英资助计划,推动多发性骨髓瘤下一代CAR-T创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1165955052","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165955052?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 21:01","pubTimestamp":1790859670,"startTime":"0","endTime":"0","summary":"传奇生物启动首届精英资助计划,推动多发性骨髓瘤下一代CAR-T创新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","MEDI","BK4505","BK4139","BK4585","LEGN","MEMS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669200411","title":"传奇生物:Huang Ying拟出售6.98万股,市值约130.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669200411","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669200411?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 06:42","pubTimestamp":1790116920,"startTime":"0","endTime":"0","summary":"南财智讯9月23日电,传奇生物(LegendBiotechCorp,纳斯达克:LEGN)前高管兼董事HuangYing提交Form144限制股出售声明。HuangYing拟出售69812股美国存托股份(ADS),合计市值约130.21万美元,拟出售日期为9月22日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609233881653835.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609233881653835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LEGN","MEMS","CANC","BK4139","MEDI","BK4505","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669156693","title":"近40位药企高管密集跳槽","url":"https://stock-news.laohu8.com/highlight/detail?id=2669156693","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669156693?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 16:07","pubTimestamp":1789978028,"startTime":"0","endTime":"0","summary":"今年前9个月,医药行业迎来了一波罕见的核心高管流动潮。超40位手握行业顶级资源的核心药企高管密集跳槽换岗,流动的触角覆盖了跨国药企、本土上市药企、创新生物科技三大赛道,从董事长、总裁到全球研发负责人、首席商务官,所有决定企业战略走向的核心岗位都在发生变动。涉及传奇生物、复星医药、安科生物、和铂医药、博锐生物、必贝特医药等20余家头部创新药企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880018985.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880018985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","MEMS","MEDX","BK4585","BK4139","LNGR","BK4505","CANC","MEDI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MEMS\",params:#limit:6,delay:false,,,undefined,":[]}}